Sponsor hub
University of Virginia clinical trial failures
Review 31 stopped clinical trials from University of Virginia, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 17
- OTHER/UNKNOWN
- 11
- EFFICACY/FUTILITY
- 2
- SAFETY
- 1
Notable sponsors
- University of Virginia
- 31
Related phases
- Phase II
- 9
- Early Phase I
- 7
- Phase I
- 6
- Unknown
- 5
- Phase III
- 3
Crawlable stopped-trial records
Open ExploreShowing up to 31 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Diabetes Mellitus, Type 1 trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
Institution transfer
Early Phase I Polycystic Ovary Syndrome trial by University of Virginia. Stop reason: OPERATIONAL.
No funding, time, or personnel to complete this study.
Phase III Septic Shock trial by University of Virginia. Stop reason: OPERATIONAL.
No funding for the study; not enough staff
Phase I Adhesive Capsulitis trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
Not able to find enough subjects
Early Phase I Triple Negative Breast Cancer trial by University of Virginia. Stop reason: OPERATIONAL.
Pharmaceutical company decided to withdraw funding and not provide drug.
Phase II Lymphoma trial by University of Virginia. Stop reason: OPERATIONAL.
Poor enrollment
Phase II Musculoskeletal Pain trial by University of Virginia. Stop reason: SAFETY.
Terminated due to hurdles of obtaining regulatory approval.
Phase III Septic Shock trial by University of Virginia. Stop reason: OPERATIONAL.
Unable to enroll subjects before PI left institution
Phase I Multiple Myeloma trial by University of Virginia. Stop reason: OPERATIONAL.
Slow accrual due to a crowded field of effective drugs by the time the study opened
Phase III Fractures, Open trial by University of Virginia. Stop reason: OPERATIONAL.
Unable to continue study due to funding and personnel restraints
Phase II Alcoholism trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
Grant was transferred to University of Maryland and results were reported under NCT02354703.
Phase I Breast Cancer Female trial by University of Virginia. Stop reason: OPERATIONAL.
slow study accrual, partially due to pandemic
Phase II Clostridium Difficile Infection trial by University of Virginia. Stop reason: OPERATIONAL.
Funding ended
Early Phase I Type 1 Diabetes trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
the study drug could not be obtained
Phase II Breast Cancer trial by University of Virginia. Stop reason: OPERATIONAL.
Lack of accrual
Phase IV Heart Failure trial by University of Virginia. Stop reason: OPERATIONAL.
Low enrollment
Unknown Hyperandrogenemia trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
The research questions was changed/de-prioritized. Only one subject completed.
Phase II Chronic Subdural Hematoma trial by University of Virginia. Stop reason: OPERATIONAL.
Accrual too slow; Study P.I. passed away.
Phase I Female Reproductive Physiology trial by University of Virginia. Stop reason: EFFICACY/FUTILITY.
Interim analysis suggested futility.
Early Phase I Hyperandrogenemia trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
The study team decided not to pursue this study.
Early Phase I Hyperandrogenemia trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
The study team decided not to pursue this study.
Early Phase I Hyperandrogenemia trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
The study team decided not to pursue this study.
Unknown Polycystic Ovary Syndrome trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
Haven't enrolled participants since 2010
Phase II Chronic Kidney Disease trial by University of Virginia. Stop reason: OPERATIONAL.
Could not obtain drug supply from manufacturer
Unknown Peripheral Artery Disease trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
No subject meeting criteria
Phase I Glioblastoma trial by University of Virginia. Stop reason: OTHER/UNKNOWN.
The pharmaceutical company (BMS) would no longer provide nivolumab for the study, so the study was terminated early.
Unknown Type 2 Diabetes trial by University of Virginia. Stop reason: OPERATIONAL.
Slow Recruitment
Unknown Rectal Cancer trial by University of Virginia. Stop reason: OPERATIONAL.
No accrual. New study opening with modified technique.
Early Phase I Pancreatic Ductal Adenocarcinoma trial by University of Virginia. Stop reason: EFFICACY/FUTILITY.
From preliminary imaging data, the study was stopped due to futility.
Phase I Hepatitis C Virus trial by University of Virginia. Stop reason: OPERATIONAL.
No funding secured
Phase II Stroke trial by University of Virginia. Stop reason: OPERATIONAL.
Slow enrollment